The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
Open accessAbstract
In certain human cancers, the expression of critical oncogenes is driven from large regulatory elements, called super-enhancers, that recruit much of the cell’s transcriptional apparatus and are defined by extensive acetylation of histone H3 lysine 27 (H3K27ac). In a subset of T-cell acute lymphoblastic leukemia (T-ALL) cases, we found that heterozygous somatic mutations are acquired that introduce binding motifs for the MYB transcription factor in a precise noncoding site, which creates a super-enhancer upstream of the TAL1 oncogene. MYB binds to this new site and recruits its H3K27 acetylase–binding partner CBP, as well as core components of a major leukemogenic transcriptional complex that contains RUNX1, GATA-3, and TAL1 itself. Additionally, most endogenous super-enhancers found in T-ALL cells are occupied by MYB and CBP, which suggests a general role for MYB in super-enhancer initiation. Thus, this study identifies a genetic mechanism responsible for the generation of oncogenic super-enhancers in malignant cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The ability of AlphaGenome to simultaneously score variant effects across all modalities accurately recapitulates the mechanisms of clinically relevant variants near the TAL1 oncogene6.”
From Advancing regulatory variant effect prediction with AlphaGenome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Detailed ALT–REF predictions for an oncogenic insertion (chr. 1: 47239296: C>ACG) characterized in ref. 6. Shown are differences between AlphaGenome predictions between the ALT and REF sequences of the variant in CD34+ CMP tracks. The ALT sequence increases expression of the TAL1 gene 7.5 kb away.”
From Advancing regulatory variant effect prediction with AlphaGenome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“We evaluated three groups of gain-of-function mutations affecting the TAL1 gene in T cell acute lymphoblastic leukaemia (T-ALL): a cluster of 5′ neo-enhancer mutations upstream of the TAL1 TSS6,33, an intronic single-nucleotide variant (SNV)34 and a 3′ neo-enhancer35.”
From Advancing regulatory variant effect prediction with AlphaGenome (2026) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“By contrast, the alternative sequence introduced a MYB motif at the variant position predicted to increase TAL1 expression, chromatin accessibility and H3K27ac chromatin marks (Fig. 6e), as discovered previously6.”
From Advancing regulatory variant effect prediction with AlphaGenome (2026) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
The Human Genome Browser at UCSC
Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., & Haussler, A. D. (2002) · Genome Research · doi:10.1101/gr.229102 · Cited by 10,400
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Histone H3K27ac separates active from poised enhancers and predicts developmental state
Creyghton, M. P., Cheng, A. W., Welstead, G. G., Kooistra, T., Carey, B. W., Steine, E. J., Hanna, J., Lodato, M. A., Frampton, G. M., Sharp, P. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016071107 · Cited by 4,302
Self-citationSelective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
FIMO: scanning for occurrences of a given motif
Grant, C. E., Bailey, T. L., & Noble, W. S. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr064 · Cited by 4,247
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143
Self-citation
Cited by
Sorted by citations
Items 701–800 of 805
Novel Insights From Comprehensive Genomic Profiling of T Cell Acute Lymphoblastic Leukemia
Teachey, D. T. (2018) · The Hematologist · doi:10.1182/hem.v15.2.8270
Mayers, J. G. (2019) · TSpace (University of Toronto)
Lara, L. I. (2019) · ProQuest Demo Repository
Modi, A., López, G., Conkrite, K. L., Su, C., Leung, T. C., Ramanan, S., Manduchi, E., Johnson, M. E., Cheung, D., Gadd, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.10.420257
Self-citationKaushik, A. C., & Sahi, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821748-1.00007-5
Chen, H., Jiang, Y., Mruk, D. D., & Cheng, C. Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-77779-1_4
Protein phase separation in cell death and survival
Chung, M. C., Liao, D., & Guan, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814208-0.00004-x
New Agents for the Treatment of T-Cell Acute Lymphoblastic Leukemia
Raikar, S. S., Teachey, D. T., & Gossai, N. P. (2022) · Springer eBooks · doi:10.1007/978-3-030-85147-7_14
Genetic Mechanisms in T-Cell Acute Lymphoblastic Leukemia
Gianni, F., & Ferrando, A. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-85147-7_2
Ri, K. C., Ri, M. R., Kim, K. H., Choe, S. I., Ri, J. H., Kim, J. H., & Ri, J. H. (2022) · Molecular Biology · doi:10.1134/s0026893322030116
Inestabilidad genética, origen y evolución del cáncer y la inmunoterapia personalizada
Maruri, J., Martínez‐Cortés, F., Odales, J., & Manoutcharian, K. (2022) · Vacunas · doi:10.1016/j.vacun.2022.01.004 · Cited by 1
Taniuchi, I. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.731254062.793537745
Cole, M., & Cumbal, N. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.731254062.793538298
Hannenhalli, S. S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735088954.793558203
Cis-acting Super-Enhancer lncRNAs as Biomarkers of Early-Stage Breast CancerPreprint
Ropri, A. S., DeVaux, R., Eng, J., Chittur, S. V., & Herschkowitz, J. I. (2021) · Research Square · doi:10.21203/rs.3.rs-800791/v1
THZ1 targeting CDK7 suppresses c-KIT transcriptional activity in gastrointestinal stromal tumoursPreprint
Sun, J., Zhang, Q., Sun, X., Xue, A., Gao, X., & Shen, K. (2022) · Research Square · doi:10.21203/rs.3.rs-1641526/v1
Study of a functional SNP rs13423388 in a novel enhancer element of schizophrenia-associated ZNF804A
Zhang, Q.-X., Zhao, D.-B.-J., Gu, R.-Y., Zhao, X., Zhao, H., Valenzuela, R. K., Xi, M.-M., Zhang, R., & Ma, J. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103191
Chen, X., Zhang, Q., Lin, J., Zhang, Y., Zhang, Y., Gui, Y., Zhang, R., Liu, T., & Li, Q. (2022) · Gene Expression Patterns · doi:10.1016/j.gep.2022.119269
In APL, noncoding mutations and SNP converge on WT1
Wu, H.-C., & de Thé, H. (2022) · Blood · doi:10.1182/blood.2022017214
Genomic instability, origin and evolution of cancer, and personalized immunotherapy
Maruri, J., Martínez‐Cortés, F., Odales, J., & Manoutcharian, K. (2022) · Vacunas (English Edition) · doi:10.1016/j.vacune.2022.10.008
Jurj, A. M., Pop, L., Zănoagă, O., Ráduly, L., & Berindan‐Neagoe, I. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_356-1
Histone acetylation insulator SET orchestrates PP2A inhibition and super-enhancer activationPreprint
He, X., Wu, D., Xu, J., Lei, Y., Lei, Y., Yu, X., & Shi, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.15.524091
Identification of Liver Cancer Driver Mutations from COSMIC Data
Sethi, A. A., & Shar, N. A. (2023) · International Journal of Cancer Management · doi:10.5812/ijcm-131281
Nameki, R. A., Chang, H. S. Y., Yu, P. H., Abbasi, F., Lin, X., Reddy, J., Haro, M., Fonseca, M. A., Freedman, M. L., Drapkin, R., et al. (2023) · eLife · doi:10.7554/elife.86360
Non-coding mutations at enhancer clusters contribute to pancreatic ductal adenocarcinomaPreprint
Wang, J., Patel, M. B., Maniati, E., Atanur, S. S., Pal, D., Rio‐Machín, A., Heward, J. A., Kocher, H. M., Fitzgibbon, J., & Pradeepa, M. M. (2023) · Research Square · doi:10.21203/rs.3.rs-3120592/v1
Serin, N. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10102
Magnani, L., Ivanoiu, D., Rosano, D., Slaven, N., Sofyalı, E., Barozzi, I., James, C. T., Cresswell, G. D., Corleone, G., Dhiman, H., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3443614/v1
SJPedPanel: A pan-cancer gene panel for childhood malignanciesPreprint
Kolekar, P. S., Balagopal, V., Dong, L., Liu, Y., Foy, S. G., Tran, Q., Mulder, H. L., Huskey, A. L. W., Plyler, E. M., Liang, Z., et al. (2023) · medRxiv · doi:10.1101/2023.11.27.23299068
ToTAL1y degraded - rapid dTAG proteolysis of TAL1 in T-cell acute lymphoblastic leukemia
Costa, J. R., & Mansour, M. R. (2023) · Haematologica · doi:10.3324/haematol.2023.284447
Self-citationSun, J., Zhang, Q., Sun, X., Xue, A., Gao, X., & Shen, K. (2022) · Figshare · doi:10.6084/m9.figshare.21069680
Edrei, Y., Levy, R., Kaye, D., Marom, A., Radlwimmer, B., & Hellman, A. (2023) · Figshare · doi:10.6084/m9.figshare.24647260
de Villiers, C. P., Downes, D. J., Goel, A., Pagnamenta, A. T., Ormondroyd, E., Sparrow, A. J., Nornes, S., Giacopuzzi, E., Rath, P., Davies, B., et al. (2024) · medRxiv · doi:10.1101/2024.08.20.24312115
Nonspecific interactions in transcription regulation and organization of transcriptional condensates
Valyaeva, A. A., & Sheval, E. V. (2024) · Biochemistry (Moscow) · doi:10.31857/s0320972524040087
A mathematical model clarifies the ABC Score formula used in enhancer-gene predictionPreprint
Nasser, J., Nam, K.-M., & Gunawardena, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.29.626072
Genetic and Epigenetic Profiles in T-ALL
Uysal, B. E., & Kulozik, A. E. (2024) · Pediatric oncology · doi:10.1007/978-3-031-71180-0_3
Xu, P., Xiao, Y., Dong, J., Xiao, Z., Li, J., & Wang, Y. (2024) · Marine Biotechnology · doi:10.1007/s10126-024-10403-y
Cai, X., Zhang, Q., Liu, B., Sun, L., & Liu, Y. (2024) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzae088
The TARZN complex binds de novo enhancer mutations and promotes oncogenic expression in T-ALLPreprint
Anuar, N. Z., Goh, C. Y., Chua, B. H., Tan, S. H., Costa, J. R., Mansour, M. R., Sanda, T., & Kappei, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.24.634708
Self-citationSuper-Enhancers: Gatekeepers of Breast Cancer Growth and ResistancePreprint
Du, J., Zhang, Z., & Tao, W. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5150923
A mathematical model clarifies the ABC Score formula used in enhancer-gene predictionPreprint
Nasser, J., Nam, K.-M., & Gunawardena, J. (2025) · eLife · doi:10.7554/elife.105740 · Cited by 1
Jiao, W., Yu, J., Zhang, Z.-M., Wu, D., Pan, J., Yin, T., Yong, Q., Zhai, Z., Zhou, B., Wu, Y., et al. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111810
Li, F., Wang, S., Chen, L., Jiang, N., Chen, X., & Li, J. (2025) · Molecular Systems Biology · doi:10.1038/s44320-025-00098-1
Lau, I., Harman, J. R., Smith, A., Denny, N., Jackson, N., Hamley, J. C., Vyas, P., Davies, J. O. J., Hughes, J. R., Crump, N. T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.16.649256
Functional enhancers: concept, screening, and validation
Lin, H., Chen, F., & Huang, J. (2025) · Scientia Sinica Vitae · doi:10.1360/ssv-2025-0113
Ng, H. L., Glaser, T. L., Robinson, M. E., Cosgun, K. N., Malysheva, V., Zhu, J., Deniz, Ö., Crump, N. T., Helian, K., Innes, A. J., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6757036/v1
Transcription Factor Networks in B-Lymphocyte Lineage Commitment
Gustafsson, J. T., Hellerstedt, K., & Sigvardsson, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00174-5
Jurj, A. M., Pop, L., Zănoagă, O., Ráduly, L., & Berindan-Neagoe, I. (2025) · Springer eBooks · doi:10.1007/978-3-032-00775-9_356
Nah, G. S. S., Matsuo, J., Bahirvani, A. G., Kimura, S., Chin, D. W. L., Ng, K. P., Koh, C. P., Mok, M. M. H., Wang, C. Q., Tergaonkar, V., et al. (2025) · Genes to Cells · doi:10.1111/gtc.70052
Self-citationEdrei, Y., Levy, R., Kaye, D., Marom, A., Radlwimmer, B., & Hellman, A. (2024) · Figshare · doi:10.6084/m9.figshare.24647291
Sun, J., Zhang, Q., Sun, X., Xue, A., Gao, X., & Shen, K. (2022) · Figshare · doi:10.6084/m9.figshare.21069677
Benedetto, C. D., Oh, J., Choudhery, Z., Shi, W., Valdés, G., & Betancur, P. A. (2022) · Figshare · doi:10.6084/m9.figshare.21321461
Benedetto, C. D., Oh, J., Choudhery, Z., Shi, W., Valdés, G., & Betancur, P. A. (2022) · Figshare · doi:10.6084/m9.figshare.21321455
Additional file 2 of Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer
Ropri, A. S., DeVaux, R. S., Eng, J., Chittur, S. V., & Herschkowitz, J. I. (2021) · Figshare · doi:10.6084/m9.figshare.16909635
Smith, C. L., Touzart, A., Simonin, M., Quang, C. T., Hypolite, G., Latiri, M., Andrieu, G. P., Balducci, E., Dourthe, M.-É., Goyal, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26562226
Additional file 1 of Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer
Ropri, A. S., DeVaux, R. S., Eng, J., Chittur, S. V., & Herschkowitz, J. I. (2021) · Figshare · doi:10.6084/m9.figshare.16909632
Edrei, Y., Levy, R., Kaye, D., Marom, A., Radlwimmer, B., & Hellman, A. (2024) · Figshare · doi:10.6084/m9.figshare.26643109
Smith, C. L., Touzart, A., Simonin, M., Quang, C. T., Hypolite, G., Latiri, M., Andrieu, G. P., Balducci, E., Dourthe, M.-É., Goyal, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26562223
Additional file 3 of Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer
Ropri, A. S., DeVaux, R. S., Eng, J., Chittur, S. V., & Herschkowitz, J. I. (2021) · Figshare · doi:10.6084/m9.figshare.16909638
Sethi, S., Vorontsov, I. E., Kulakovskiy, I. V., Greenaway, S., Williams, J., Vsevolod, M., Brown, S. D. M., Simon, M. M., & Mallon, A.-M. (2020) · Figshare · doi:10.6084/m9.figshare.13181407
Benedetto, C. D., Oh, J., Choudhery, Z., Shi, W., Valdés, G., & Betancur, P. A. (2022) · Figshare · doi:10.6084/m9.figshare.21321458
Benedetto, C. D., Oh, J., Choudhery, Z., Shi, W., Valdés, G., & Betancur, P. A. (2022) · Figshare · doi:10.6084/m9.figshare.21321464
Edrei, Y., Levy, R., Kaye, D., Marom, A., Radlwimmer, B., & Hellman, A. (2024) · Figshare · doi:10.6084/m9.figshare.26643115
Edrei, Y., Levy, R., Kaye, D., Marom, A., Radlwimmer, B., & Hellman, A. (2024) · Figshare · doi:10.6084/m9.figshare.26643106
Edrei, Y., Levy, R., Kaye, D., Marom, A., Radlwimmer, B., & Hellman, A. (2024) · Figshare · doi:10.6084/m9.figshare.26643112
Huang, G., Zhang, X., Xu, Y., Chen, S., Cao, Q., Liu, W. G., Fu, Y., Jia, Q., Shen, J., Yin, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26670855
Targeting super-enhancer-driven MAB21L2 suppresses neuroblastoma growth and migration
Chen, Y., Wu, D., Yang, C., Pan, J., Tao, Y., Zhuo, R., Li, G., Yu, J., Li, X., Pan, J., et al. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.114923
MiRNA degradation by a conserved target RNA regulates animal behavior
Bitetti, A. (2017) · theses.fr (ABES) · doi:10.70675/30bd04eczc40bz4791z8cffz311f59320c18
Zebrafish as a model to determine conserved gene regulatory mechanisms in vertebrates
Perez-Rico, Y. A. (2018) · theses.fr (ABES) · doi:10.70675/3b7b3dc7z2a68z4c2czbdefz57bf4abbe1cc
Peltier, A. (2019) · theses.fr (ABES) · doi:10.70675/8acfe7dbz9469z4a3ez9887z90ca9b7adfaa
Etude des effecteurs de la voie Ca2+/Calmoduline dans les leucémies aiguës lymphoblastiques T
Catherinet, C. (2017) · theses.fr (ABES) · doi:10.70675/aa90c6a6z8815z4b8bz81ccz3038ffc2614d
Caractérisation des enhancers dérégulés dans la leucémie aiguë lymphoblastique de type T
España, A. P. (2019) · theses.fr (ABES) · doi:10.70675/5c13bdf2zac72z45c4z91e7z396bdaa5ddc4
Rôle et détection des enhancers au cours de la différentiation normale et en contexte leucémique
Pioger, L. (2020) · theses.fr (ABES) · doi:10.70675/9c32f63bza75fz4561z8619zaa33713157b5
Analyse à haute résolution de la structure spatiale des chromosomes eucaryotes
Carron, L. (2019) · theses.fr (ABES) · doi:10.70675/54e488fdzb7afz40cazaa57z583979c137f4
Groeneveld, C. S. (2023) · theses.fr (ABES) · doi:10.70675/10c68a9dz9fcaz441ez9760zd2be90dbb9d0
Comprehensive mapping of human genetic variation at Epromoters
Wan, J. (2024) · theses.fr (ABES) · doi:10.70675/a2e4bbffze012z41baz8c31z2f84f271295e
Co-option of lineage plasticity as a hallmark of multipotent acute leukemias
Gutierrez, A., & Kentsis, A. (2026) · Blood Neoplasia · doi:10.1016/j.bneo.2026.100231 · Cited by 1
Self-citationEvolving computational paradigms for noncoding variant pathogenicity prediction
Wang, B., Song, S., Cheng, S. O. N. G., Lin, Y., Yu, L., Li, Y., & Chen, X. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1761673
Sensitive detection of somatic mutations in GC-rich cancer gene promoters
Qi, M., Dave, P. S., Francis, N., DeFelice, M. T., Pollock, S., Corbitt, H., Mitsiades, I. R., Wang, G., Frère, P., Fox, A., et al. (2026) · NAR Cancer · doi:10.1093/narcan/zcag011
Terekhanova, N. V., Chen, X., Chow, K.-H., Liu, Y., Shao, Y., Dong, L., Ju, B., Vinayachandran, V., Zubair, H., Hagiwara, K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.03.722504
Self-citationLi, L., Wang, J., & Wan, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.727257
qChIP-MS reveals the local chromatin composition by label-free quantitative proteomics
Yong, W. K., Anuar, N. Z., Sin, Z. W., Tan, E. S. R., Rane, G., Shao, X., Goh, C. Y., Khanchandani, V., Kuan, V. L. S., Ong, P. F., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73609-9 · Cited by 4
Self-citation3D chromatin architecture in cancer: mechanisms of dysregulation and emerging therapeutic strategies
Jang, S., & Yoo, K. H. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01748-6 · Cited by 1
Chromatin folding and function
Moreira-Ferreira, D. N., Silva, J. L., & de Oliveira, G. A. P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-99507-8.00070-6
Bhansali, R. S., Long, J. S., Pölönen, P., Isobe, T., Wang, S., Zhang, S., Geng, Z., Tausif, A., Antopia, M. C., Aboreden, N. G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.29.733236
Three-dimensional genome architecture: from contacts to mechanisms
Hoboth, P., & Sztacho, M. (2026) · Advances in Biological Regulation · doi:10.1016/j.jbior.2026.101171
Prognostic and Predictive Biomarkers in T-Lymphoblastic Leukemia
Repnikova, E. A., Lyalin, D. A., & SUKHANOVA, M. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-26557-9_14
Yu, M., Das, P., Zhang, X., & Cheng, X. (2026) · Molecular Oncology · doi:10.1002/1878-0261.70304
OutFOXing a FENDRR bender in T-ALL
Kosasih, H. J., & de Bock, C. E. (2026) · Blood · doi:10.1182/blood.2026033890
Schüler, L., Winkler, R. E., Gonçalves-Dias, J., Schuschel, K., Issa, H., Verboon, L., Wei, X., Çetin, R., Matthess, Y., Kaulich, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.18.745242
Molecular targeting of CDK9 in oncology therapeutics: avenues for translational impact
Liu, T., Liu, Z., Wei, W., Wang, S., Wang, S., Zhang, Y., Gao, Z., & Wu, W. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2723483
WNK1: an atypical kinase vulnerability in T-ALL
Borin, C., & Ntziachristos, P. (2026) · Blood · doi:10.1182/blood.2026034652
Costa, J. R., Li, Y., Ahrabi, S., Li, Z., Rapoz-D’Silva, T., Krulik, M. E., Hyseni, S., Morrow, G., Guo, Y., Look, A. T., et al. (2026) · STAR Protocols · doi:10.1016/j.xpro.2026.104817
Self-citation
Metadata
- Authors
- Mansour, M. R., Abraham, B. J., Anders, L., Berezovskaya, A., Gutierrez, A., Durbin, A. D., Etchin, J., Lawton, L., Sallan, S. E., Silverman, L. B., Loh, M. L., Hunger, S. P., Sanda, T., Young, R. A., & Look, A. T.
- Affiliations
- Harvard University (US)
- Whitehead Institute for Biomedical Research (US)
- Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
- Boston Children's Hospital (US)
- University of California, San Francisco (US)
- Children's Hospital Colorado (US)
- National University of Singapore (SG)
- Corresponding author
- Abraham, Brian J.
- Anders, Lars
- Young, Richard A.
- Look, A. Thomas
- ORCID
- Venue
- Science
- Published
- 2014-12-12
- Volume
- 346
- Issue
- 6215
- Pages
- 1373-1377
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4720521
- OpenAlex
- W2082414039
- Cited by
- 801
- References
- 46
- Citations by year
- 2026: 32 · 2025: 49 · 2024: 61 · 2023: 77 · 2022: 84 · 2021: 85 · 2020: 80 · 2019: 62 · 2018: 65 · 2017: 77 · 2016: 76 · 2015: 49 · 2014: 4
- FWCI
- 28.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- UCL Discovery (University College London) (submittedVersion)
- PMC
- Funders
- National Human Genome Research Institute (R01HG002668)
- National Cancer Institute (R21CA167124, CA114766, CA30969, R01CA176746, CA‐98413, U10CA098413, U24CA114766, U10CA030969, P01CA068484, CA 29139, R01CA120215, 5P01CA68484, U10CA029139, U10CA098543, P01CA109901, CA167124, CA120215, CA-98543, P30CA014051)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Keywords
- super-enhancers, T-cell acute lymphoblastic leukemia, MYB transcription factors, somatic mutations, H3K27 acetylation, CBP, RUNX1, GATA3, transcriptional regulation, oncogene expression
- MeSH terms
- T-Cell Acute Lymphocytic Leukemia Protein 1, Acetylation, Base Sequence, Binding Sites, Enhancer Elements, Genetic, Histones, Humans, Molecular Sequence Data, Mutation, Oncogenes, Proto-Oncogene Proteins, Gene Expression Regulation, Neoplastic, Proto-Oncogene Proteins c-myb, DNA, Intergenic, Cell Line, Tumor, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, INDEL Mutation, Protein Interaction Domains and Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
